A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart

verducatib (BI 1291583) - Boehringer Ingelheim

moxifloxacin intravenous - Generic mfg.

A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart (clinicaltrials.gov) - Sep 10, 2026 - P1 | N=56 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting
Enrollment open

http://clinicaltrials.gov/ct2/show/NCT07760246

Sep 10, 2026